Concepedia

Mary Browning

MB

10

Publications

572

Citations

10

H-Index

2003

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Mary Browning is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pathology.

Top concepts

Publications per year

2003–2013

10

Publications

10

Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia

Susan O’Brien, Hagop M. Kantarjian, Deborah A. Thomas et al. · Cancer · 2003 · 222 citations · Full text

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy

Constantine S. Tam, Susan O’Brien, Susan Lerner et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 98 citations

Activity of alemtuzumab in patients with CD52‐positive acute leukemia

Raoul Tibes, Michael J. Keating, Alessandra Ferrajoli et al. · Cancer · 2006 · 97 citations

Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults

Sara Shinnick, Mary Browning, Susannah E. Koontz · Journal of Pediatric Oncology Nursing · 2013 · 37 citations

, , +13

Combined Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR), an Active Frontline Regimen for High-Risk Patients with CLL.

William G. Wierda, Susan O’Brien, Alessandra Ferrajoli et al. · Blood · 2007 · 27 citations

Rows per page

1–5 of 10